AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.
from Reuters: Health News https://ift.tt/2MYiSxT
via
IFTTT
0 comments:
Post a Comment